To include your compound in the COVID-19 Resource Center, submit it here.

Peg-Intron approved for hepatitis C in U.S.

Schering-Plough (SGP) said that its Peg-Intron

Read the full 69 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE